MARKER THERAPEUTICS, INC. Deferred Compensation Equity
MARKER THERAPEUTICS, INC. (MRKR) had Deferred Compensation Equity of $0 as of 2012-06-30, per its 10-Q/A filed 2012-09-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2013-05-15
- 2012-06-30: Deferred Compensation Equity $0.00.
- 2011-12-31: Deferred Compensation Equity $35.97K.
- 2011-09-30: Deferred Compensation Equity $86.88K.
- 2011-06-30: Deferred Compensation Equity $142.50K.
| Period end | Deferred Compensation Equity |
|---|---|
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-12 |
| 2011-12-31 | $35.97K 10-K · filed 2013-05-15 |
| 2011-09-30 | $86.88K 10-Q · filed 2011-11-21 |
| 2011-06-30 | $142.50K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |